Cytopathology and Histopathology

Clinical & Molecular Cytopathology

Molecular Cytopathology is an emerging discipline within Cytopathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Cervical cancer is the third most common type of cancer among women worldwide. The infection and persistence of human papillomavirus (HPV) is the essential condition for this type of disease. However, only HPV infection is not enough for cervical pathogenesis are necessary cofactors and activation of intracellular and extracellular mechanisms to start.

In the conventional Pap smear, the physician collecting the cells smears them on a microscope slide and applies a fixative. In general, the slide is sent to a laboratory for evaluation. The studies include Liquid-based monolayer cytology and Human papillomavirus testing.

The overall cytology market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America attributed the largest share in the market in terms of revenue owing to the increasing incidences of cancer in this region. As stated by American Cancer Society, U.S. is expected to hold one third of the total cancer cases worldwide. Europe is accounted for the second largest region in terms of growth of histology and cytology market. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to continuous technological advancements and rapidly increasing awareness regarding prevention procedures of cell based chronic diseases in this region. High unmet needs of the population residing in this region, is expected to further boost the growth of this region.